13,994 Shares in Accolade, Inc. (NASDAQ:ACCD) Bought by Wealth Enhancement Advisory Services LLC

Wealth Enhancement Advisory Services LLC acquired a new position in shares of Accolade, Inc. (NASDAQ:ACCD) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 13,994 shares of the company’s stock, valued at approximately $48,000.

Other hedge funds also recently added to or reduced their stakes in the company. Laird Norton Wetherby Trust Company LLC acquired a new position in Accolade during the 4th quarter worth $38,000. Boothbay Fund Management LLC acquired a new position in Accolade during the 4th quarter worth $43,000. Pilgrim Partners Asia Pte Ltd acquired a new position in Accolade during the 4th quarter worth $54,000. RPO LLC acquired a new position in Accolade during the 4th quarter worth $57,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd grew its holdings in Accolade by 49.9% during the 4th quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd now owns 17,804 shares of the company’s stock worth $61,000 after acquiring an additional 5,929 shares in the last quarter. 84.99% of the stock is owned by institutional investors and hedge funds.

Accolade Stock Performance

NASDAQ ACCD opened at $7.02 on Thursday. Accolade, Inc. has a one year low of $3.08 and a one year high of $7.03. The company has a 50-day simple moving average of $7.02 and a 200-day simple moving average of $6.32. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.63 and a current ratio of 2.63. The firm has a market capitalization of $575.59 million, a PE ratio of -3.12 and a beta of 2.10.

Analysts Set New Price Targets

Separately, Piper Sandler lowered shares of Accolade from a “strong-buy” rating to a “hold” rating in a report on Wednesday, March 5th. Thirteen investment analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $6.51.

Accolade Profile

Accolade, Inc, together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and primary care physicians.